Cargando…

Modern Genome Editing Technologies in Huntington’s Disease Research

The development of new revolutionary technologies for directed gene editing has made it possible to thoroughly model and study NgAgo human diseases at the cellular and molecular levels. Gene editing tools like ZFN, TALEN, CRISPR-based systems, NgAgo and SGN can introduce different modifications. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malankhanova, Tuyana B., Malakhova, Anastasia A., Medvedev, Sergey P., Zakian, Suren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389024/ https://www.ncbi.nlm.nih.gov/pubmed/28128770 http://dx.doi.org/10.3233/JHD-160222

Ejemplares similares

A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington’s Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities
por: Malankhanova, Tuyana, et al.
Publicado: (2020)

The Cutting Edge of Disease Modeling: Synergy of Induced Pluripotent Stem Cell Technology and Genetically Encoded Biosensors
por: Valetdinova, Kamila R., et al.
Publicado: (2021)

Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells
por: Morozova, Ksenia N., et al.
Publicado: (2018)

Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease
por: Grigor’eva, Elena V., et al.
Publicado: (2023)

Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H(2)O(2)
por: Ustyantseva, Elizaveta, et al.
Publicado: (2022)

TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
por: Nemudryi, A. A., et al.
Publicado: (2014)

Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents
por: Zakharenko, Alexandra L., et al.
Publicado: (2023)

Genetically Encoded Fluorescent Biosensors for Biomedical Applications
por: Ovechkina, Vera S., et al.
Publicado: (2021)

New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition
por: Dyrkheeva, Nadezhda S., et al.
Publicado: (2021)

Variability of Sequence Surrounding the Xist Gene in Rodents Suggests Taxon-Specific Regulation of X Chromosome Inactivation
por: Shevchenko, Alexander I., et al.
Publicado: (2011)

Structure and expression pattern of Oct4 gene are conserved in vole Microtus rossiaemeridionalis
por: Medvedev, Sergey P, et al.
Publicado: (2008)

CellCountCV—A Web-Application for Accurate Cell Counting and Automated Batch Processing of Microscopic Images Using Fully Convolutional Neural Networks
por: Antonets, Denis, et al.
Publicado: (2020)

MicroRNA editing patterns in Huntington’s disease
por: Guo, Shiyong, et al.
Publicado: (2022)

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling
por: Bayzigitov, Daniel R., et al.
Publicado: (2016)

Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor
por: Dyrkheeva, Nadezhda S., et al.
Publicado: (2023)

Genome-wide profiling and differential expression of microRNA in rat pluripotent stem cells
por: Sherstyuk, Vladimir V., et al.
Publicado: (2017)

Cell-based technologies for Huntington’s disease
por: Haddad, Mônica Santoro, et al.
Publicado: (2016)

Model Systems of Motor Neuron Diseases As a Platform for Studying Pathogenic Mechanisms and Searching for Therapeutic Agents
por: Valetdinova, K. R., et al.
Publicado: (2015)

Applications of Genome Editing Technology in Research on Chromosome Aneuploidy Disorders
por: Akutsu, Silvia Natsuko, et al.
Publicado: (2020)

Molecular Research on Huntington’s Disease
por: Valor, Luis M.
Publicado: (2023)

Mild phenotype of knockouts of the major apurinic/apyrimidinic endonuclease APEX1 in a non-cancer human cell line
por: Kim, Daria V., et al.
Publicado: (2021)

PARP1 Gene Knockout Suppresses Expression of DNA Base Excision Repair Genes
por: Zakharenko, A. L., et al.
Publicado: (2023)

Fostering responsible research with genome editing technologies: a European perspective
por: Chneiweiss, Hervé, et al.
Publicado: (2017)

Progress of genome editing technology and developmental biology useful for radiation research
por: Miura, Kento, et al.
Publicado: (2021)

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications
por: Akram, Fatima, et al.
Publicado: (2022)

Genome-Editing Technologies for Enhancing Plant Disease Resistance
por: Andolfo, Giuseppe, et al.
Publicado: (2016)

Inhalation delivery technology for genome-editing of respiratory diseases
por: Chow, Michael Y.T., et al.
Publicado: (2021)

Therapeutic Application of Genome Editing Technologies in Viral Diseases
por: Kim, Tae Hyeong, et al.
Publicado: (2022)

New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
por: Dyrkheeva, Nadezhda S., et al.
Publicado: (2021)

Modern Prometheus: editing the human genome with Crispr-Cas9
por: Kozubek, Jim
Publicado: (2016)

Modern Approaches to the Genome Editing of Antibiotic Biosynthetic Clusters in Actinomycetes
por: Buyuklyan, J. A., et al.
Publicado: (2023)

Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis
por: Mak, Michelle C. E., et al.
Publicado: (2023)

Advances in application of genome editing in tomato and recent development of genome editing technology
por: Xia, Xuehan, et al.
Publicado: (2021)

Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1
por: Il’ina, Irina V., et al.
Publicado: (2020)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington’s Disease Mouse Model
por: Ekman, Freja K., et al.
Publicado: (2019)

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
por: Li, Zhen-Hua, et al.
Publicado: (2023)

Modern genome editing meets telomeres: the many functions of TPP1
por: Karlseder, Jan
Publicado: (2014)

Genome-editing Technologies for Gene and Cell Therapy
por: Maeder, Morgan L, et al.
Publicado: (2016)

Genome-editing technologies for gene correction of hemophilia
por: Park, Chul-Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_01io144a3ccqbn4ttothu1582m